Netherlands· NL-6177612d85ac
Tobrabact, oogdruppels, oplossing 3 mg/ml
A tobramycin product containing tobramycine, registered in Netherlands by Medicom Healthcare Ireland Limited. The same ATC class is registered in 10 of our 19 countries.
Checked against CBG-MEB (Netherlands) on
Informational only — not a medical device.
Where it is registered
Tobramycin is registered in 10 of 19 countries.
Countries holding a registration under ATC S01AA12 (tobramycin), each read from that country’s own register.
- This record: Netherlands, from CBG-MEB (Netherlands)
- 7 of them publish a price we can compare per daily dose
Tobramycin · ATC S01AA12
10 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Finlandprice
- Netherlands
- Norwayprice
- Polandprice
- Switzerlandprice
- United Kingdom
- United Statesprice
The record
At a glance
CBG-MEB (Netherlands)- Active substance
- TOBRAMYCINE
- Manufacturer
- Medicom Healthcare Ireland Limited
- Country
- Netherlands (NL)
- ATC code
- S01AA12
- ATC class
- Tobramycin
- Reimbursed
- Not published by this register
- Source register
- CBG-MEB (Netherlands)
- Last checked
- September 29, 2026
Packs & prices · 1
- cbg_meb_id26393
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Tobramycin in 16 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- PolandTobrexInPharm Sp. z o.o.
- United StatesTobramycinProficient Rx LP
- FinlandTobrexAlcon Couvreur N.V.
- BelgiumTobravisc 3 mg/mlNovartis Pharma
- CzechiaTOBREXNovartis s.r.o., Praha
- United KingdomBramitob 300mg/4ml nebuliser solution 4ml ampoulesChiesi Ltd
- GermanyBramitobChiesi Gmbh
- SpainBRAMITOB 300 mg/4 ml SOLUCION PARA INHALACION POR NEBULIZADORChiesi España S.A.U.
Authorised across Europe · EMA
The same active substance is authorised in 30 EEA countries. Names it is sold under:
- Austria · Bramitob, Tobi
- Belgium · Obracin, Tobi
- Bulgaria · Tобрекс, Тобрамизил
- Cyprus · Bramitob, Ikobel
- Czechia · Bramitob, Tobramycin Vioser
- Germany · Bramitob, Gernebcin
- Denmark · Nebcina, Tobi
- Estonia · Tobramycin Via Pharma, Tobrex
- Spain · Bramitob, Tobrabact
- Finland · Tobi
- France · Nebcine, Tobi
- United Kingdom (Northern Ireland) · Bramitob, Munuza
- Greece · Bramitob, Eyetobrin
- Croatia · Bramitob, Tobrex
- Hungary · Bramitob, Brulamycin
- Ireland · Bramitob, Tobi
- Iceland · Tobi Podhaler, Vantobra
- Italy · Bramicil, Bramitob
- Liechtenstein · Tobi Podhaler, Vantobra
- Lithuania · Bramitob, Tobramycin Via Pharma
- Luxembourg · Obracin, Tobi
- Latvia · Bramitob, Tobramycin Via Pharma
- Malta · Tobi, Tobrex
- Norway · Bramitob, Nebcina
- Poland · Bramitob, Tobramycin Via Pharma
- Portugal · Bramitob, Tobi
- Romania · Tobi, Tobramicină Sun
- Sweden · Bramitob, Nebcina
- Slovenia · Tobrex
- Slovakia · Bramitob, Tobrex
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of CBG-MEB (Netherlands). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/3864bdb2-ab00-4373-9bb3-a26d86b3d2d5 GET /v1/drugs/3864bdb2-ab00-4373-9bb3-a26d86b3d2d5?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Oogdruppels, oplossing",
"route": "Oculair gebruik",
"soort": "RVG",
"source": "cbg_meb",
"smpc_url": "https://www.geneesmiddeleninformatiebank.nl/smpc/h26393_smpc.pdf",
"strength": null,
"atc_label": "Tobramycin",
"detail_url": "https://www.geneesmiddeleninformatiebank.nl/nl/rvg26393",
"excipients": [
"BENZALKONIUMCHLORIDE",
"BOORZUUR (E 284)",
"NATRIUMCHLORIDE",
"NATRIUMSULFAAT 0-WATER (E 514 (I))",
"TYLOXAPOL",
"WATER, GEZUIVERD"
],
"substances": [
"TOBRAMYCINE"
],
"leaflet_url": "https://www.geneesmiddeleninformatiebank.nl/bijsluiters/h26393.pdf",
"authorised_at": "2001/07/17",
"procedure_number": "FR/H/0177/001",
"dispensing_status": "Uitsluitend recept",
"registration_number": "26393",
"additional_monitoring": "N"
}See everything about tobramycin.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.